What is MYNZ's earnings growth forecast for 2025-2025?
(NASDAQ: MYNZ) Mainz Biomed Nv's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Mainz Biomed Nv's earnings in 2025 is -$21,650,663.
In 2025, MYNZ is forecast to generate -$21,338,048 in earnings, with the lowest earnings forecast at -$21,338,048 and the highest earnings forecast at -$21,338,048.
What is MYNZ's revenue growth forecast for 2025-2025?
(NASDAQ: MYNZ) Mainz Biomed Nv's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Mainz Biomed Nv's revenue in 2025 is $893,991.
In 2025, MYNZ is forecast to generate $3,247,094 in revenue, with the lowest revenue forecast at $3,247,094 and the highest revenue forecast at $3,247,094.
What is MYNZ's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: MYNZ) forecast ROA is -161.19%, which is lower than the forecast US Diagnostics & Research industry average of 9.03%.
What is MYNZ's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: MYNZ) Mainz Biomed Nv's current Earnings Per Share (EPS) is -$22.36. In 2025, MYNZ's EPS is forecast to hit -$9.20 (min: -$9.20, max: -$9.20).
What is MYNZ's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: MYNZ) forecast ROE is -352.9%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.